Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Forgive my ignorance but how would a takeover work or is it even possible once license deals are made and a possible joint venture? Can someone still offer for the whole package once these are in place? Obviously, if so, the buyout price is far higher im assuming?
Amazing news. That was my initial thought - if the continued dosing of previous patients could contribute to P1b study. Great news regardless and a massive day!
If proven? Sorry if ive missed something but the last update we were seeing significant therapeutic levels of dox inside the tumour. I dont understand why this isnt enough to run with the lower dose more frequently and let the search for MTD continue.
A issue thats been annoying me is, why can they not start P2 just now if the RP2D is to be no where near the MTD? They must have a very good idea of the recommended dose at the moment and the search for MTD can run alongside?
I know SD was was for fund managers and ii but the public and normal people need a normal explanation. No fancy figures just a direct comparison to what we have now and how better it is. The data is compelling but it needs simplified further. This is what will grab people’s attention and get Avacta’s name into mainstream media.
I know its been said before but there is no way Avacta retains control over this. Big pharma have now seen this extremely good data from SD and offers will be coming very soon (apparently already). The whole ‘retain lead asset’ line - well, you would say that. The only issue for big pharma is, they need to dig deeper now.